Significance of vitamin D deficiency correction in the combination treatment of metabolic disorders in patients with polycystic ovary syndrome


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To assess 25(OH)D deficiency correction in the combination treatment of metabolic disorders in patients with polycystic ovary syndrome (PCOS). Subject and methods. A total of 44 patients aged 31.32±5.05 years with PCOS were examined and randomized into 2 groups: 1) patients who received combined oral contraceptives (COC), biguanides, and colecalciferol; 2) those who used COC and biguanides. A comparison group consisted of 22 healthy women matched for gender and age. PCOS was verified in accordance with the 2012 ESHRE/ASRM diagnostic criteria. 25(OH) vitamin D (ng/ml) was measured by enzyme immunoassay. Fasting glucose and insulin and HOMA insulin resistance index were investigated. The Beck Depression Inventory was applied. The data were processed using the R-system. Results. The patients with PCOS were found to have obvious 25(OH)D deficiency associated with hyperandrogenism, hyperglycemia, hyperinsulinemia, insulin resistance, and depression. The administration of colecalciferol led to better carbohydrate metabolism, alleviated the manifestations of PCOS, and reduced waist circumference, waist-hip ratio, and depression. Conclusion. Correction of 25(OH)D deficiency contributes to the improvement of metabolic and psychological parameters and fertility.

Full Text

Restricted Access

About the authors

Maria Vladimirovna Matveeva

MAMME Clinic Ltd Company

Email: matveeva.mariia@yandex.ru
endocrinologist of advisory department Advisory Branch, MAMME Clinic Ltd Company.

Julia Gennadyevna Samoilova

Siberian State Medical University, Ministry of Health of Russia

Email: samoilova_y@inbox.ru
Ph.D., Professor, Department of Endocrinology and Diabetology

References

  1. Маркова Т.Н., Марков Д.С., Маркелова Т.Н., Нигматуллина С.Р., Баимкина Э.В., Борисова Л.В. и др. Распространенность дефицита витамина D и факторов риска остеопороза у лиц молодого возраста. Вестник Чувашского университета. 2012; 3: 441-6. [Markova T.N., Markov D.S., Markelova T.N., Nigmatullina S.R., Baimkina Je.V., Borisova L.V. et al. The prevalence of vitamin D deficiency and risk factors for osteoporosis in young people. Vestnik Chuvashskogo universiteta. 2012; 3: 441-46. (in Russian)]
  2. Вербовой А.Ф., Шаронова Л.А., Капишников А.В., Демидова Д.В. Витамин D3, остеопротегерин и другие гормонально-метаболические показатели у женщин с сахарным диабетом 2 типа. Ожирение и метаболизм. 2012; 4: 23-7. [Verbovoj A.F., Sharonova L.A., Kapishnikov A.V., Demidova D.V. Vitamin D3, osteoprotegerin and other hormonal and metabolic parameters in women with diabetes mellitus type 2. Ozhirenie i metabolizm. 2012; 4: 23-27. (in Russian)]
  3. Каронова Т.Л., Гринева Е.Н., Никитина И.Л., Цветкова Е.В., Тодиева А.М., Беляева О.Д. и др. Распространенность дефицита витамина D в Северо-Западном регионе РФ среди жителей г. Санкт-Петербурга и г. Петрозаводска. Остеопороз и остеопатии. 2013; 3: 3-7. [Karonova T.L., Grineva E. N., Nikitina I. L., Cvetkova E. V., Todieva A. M., Beljaeva O.D. et al. The prevalence of vitamin D deficiency in the Northwest region of the Russian Federation among the residents of St. Petersburg and Petrozavodsk. Osteoporoz i osteopatii. 2013; 3: 3-7. (in Russian)]
  4. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to Polycystic Ovary Syndrome (PCOS). Hum. Reprod. 2004; 19(1): 41-7.
  5. Paffoni A., Ferrari S., Vigano P., Pagliardini L., Papaleo E., Candiani M. et al. Vitamin D deficiency and infertility: insights from in vitro fertilization cycles. J. Clin. Endocrinol. Metab. 2014; 99(11): E2372-6.
  6. Moini A., Shirzad N., Ahmadzadeh M., Hosseini R., Hosseini L., Sadatmahalleh S. Comparison of 25-hydroxyvitamin D and calcium levels between polycystic ovarian syndrome and normal women. Int. J. Fertil. Steril. 2015; 9(1): 1-8.
  7. Kim J.J., Choi Y.M., Chae S.J., Hwang K.R., Yoon S.H., Kim M.J. et al. Vitamin D deficiency in women with polycystic ovary syndrome. Fertil. Steril. 2013; 99(6): 1779-85.
  8. Figurovâ J., Dravecká I., Javorský M., Petríková J., Lazúrová I. Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities. Wien. Klein. Wochenschr. 2015; Mar. 19.
  9. Кузнецова И.В. Роль инсулиносенситайзеров и препаратов кальция с витамином D3 в комплексной терапии синдрома поликистозных яичников. Проблемы эндокринологии. 2013; 59(1): 49-56. [Kuznecova I.V. Role insulinosensitayzerov and calcium supplementation with vitamin D3 in the treatment of polycystic ovary syndrome. Problemyi endokrinologii. 2013; 1: 49-56. (in Russian)]
  10. Faraji R., Sharami S.H., Zahiri Z., Asgharni M., Kazemnejad E., Sadeghi S. Evaluation of relation between anthropometric indices and vitamin D concentrations in women with polycystic ovarian syndrome. J. Family Reprod. Health. 2014; 8(3): 123-9.
  11. Kozakowski J., Kapuścińska R., Zgliczyński W. Associations of vitamin D concentration with metabolic and hormonal indices in women with polycystic ovary syndrome presenting abdominal and gynoidal type of obesity. Ginekol. Pol. 2014; 85(10): 765-70.
  12. Firouzabadi R., Aflatoonian A., Modarresi S., Sekhavat L., Mohammad Taheri S. Therapeutic effects of calcium & vitamin D supplementation in women with PCOS. Eur. J. Endocrinol. 2009; 161(4): 575-82.
  13. Thomson R.L., Spedding S., Brinkworth G.D., Noakes M., Buckley J.D. Seasonal effects on vitamin D status influence outcomes of lifestyle intervention in overweight and obese women with polycystic ovary syndrome. Fertil. Steril. 2013; 99(6): 1779-85.
  14. Андреева Е.Н., Шереметьева Е.В., Григорян О.Р., Дедов И.И. Психологические особенности больных при различных фенотипах синдрома поликистозных яичников. Проблемы репродукции. 2013; 3: 25-9. [Andreeva E.N., Sheremet’eva E.V., Grigorjan O.R., Dedov I.I. Psychological characteristics of patients with different phenotypes of polycystic ovary syndrome. Problemyi reproduktsii. 2013; 3: 25-29. (in Russian)]
  15. Moran L.J., Teede H.J., Vincent A.J. Vitamin D is independently associated with depression in overweight women with and without PCOS. J. Gynecol. Endocrinol. 2015; 31(3): 179-82.
  16. Дедов И.И., Мельниченко Г.А. Клинические рекомендации. Дефицит витамина D: диагностика, лечение, профилактика. М.: Российская ассоциация эндокринологов, ФГБУ «Эндокринологический научный центр» Минздрава России; 2015. 75с. [Dedov I.I., Mel‘nichenko G.A. Clinical guidelines. Vitamin D deficiency: diagnosis, treatment, prevention. Moscow: Russian Association of endocrinologists, FGBI “Endocrinology Research Center” Russian Ministry of Health; 2015; 75 p. (in Russian)]
  17. Андрющенко А.В., Дробижев М.Ю., Добровольский А.В. Сравнительная оценка шкал CES-D, BDI и HADS(d) в диагностике депрессий в общемедицинской практике. Журнал неврологии и психиатрии им. С.С. Корсакова. 2003; 103(5): 34-9. [Andrjushhenko A.V., Drobizhev M.Ju., Dobrovol’skij A.V. Comparative assessment scale CES-D, BDI and HADS (d) in the diagnosis of depression in general practice. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2003; 5: 34-9. (in Russian)]
  18. Гланц С. Медико-биологическая статистика. Пер. с англ. М.: Практика; 1998. 459с. [Glanc S. Biomedical statistics: translate from English. M.: Practice, 1998. 459 p. (in Russian)].
  19. Buggio L., Roncella E., Somigliana E., Vercellini P. Vitamin D and benign gynaecological diseases: a critical analysis of the current evidence. Gynecol. Endocrinol. 2015; Nov. 16: 1-5.
  20. Krul-Poel Y.H., Snackey C., Louwers Y., Lips P., Lambalk C.B., Laven J.S. et al. The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review. Eur. J. Endocrinol. 2013; 169(6): 853-65.
  21. Jia X.Z., Wang Y.M., Zhang N., Guo L.N., Zhen X.L., Li H., Wei L. Effect of vitamin D on clinical and biochemical parameters in polycystic ovary syndrome women: a meta-analysis. J. Obstet. Gynaecol. Res. 2015; 41(11): 1791-802.
  22. Irani M., Seifer D.B., Grazi R.V., Julka N., Bhatt D., Kalgi B. et al. Vitamin D supplementation decreases TGF-ß1 bioavailability in PCOS: a randomized placebo-controlled trial. J. Clin. Endocrinol. Metab. 2015; 100(11): 4307-14.
  23. Dasgupta S., Dutta J., Annamaneni S., Kudugunti N., Battini M.R. Association of vitamin D receptor gene polymorphisms with polycystic ovary syndrome among Indian women. Indian J. Med. Res. 2015; 142(3): 276-85. doi: 10.4103/0971-5916.166587.
  24. Irani M., Merhi Z. Role of vitamin D in ovarian physiology and its implication in reproduction: a systematic review. Fertil. Steril. 2014; 102(2): 460-8.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies